LifeSci Venture Partners
Venture capitalNew York · Series A–Series C · 1 people tracked
Investment thesis
LifeSci Ventures invests in life sciences companies with a focus on clinical validation and scientific rigor. The firm leverages deep healthcare expertise to partner with founders through investor development, financing strategy, and commercial launch execution. The firm emphasizes being a steady, value-adding partner across multiple company investments.
Source: firm website, verified Jul 21, 2026.
Team · 1 people
from the firm's websiteMedical professional with extensive pharmaceutical industry background including prior roles as Chief Medical Officer at Thar Pharmaceuticals and Vice President of Medical Affairs at Lev Pharmaceuticals. Trained in internal medicine and holds an M.D. from Albert Einstein College of Medicine.
What they invest in
from 1 of 4 portfolio companiesDeep Tech ×1Enterprise Software ×1New Materials ×1
Investments · 4 tracked
founders shown can be your intro pathIridia embeds molecular markers into physical products to verify authenticity, enable traceability, and carry embedded data without altering appearance or function. The technology serves manufacturers and brands across various materials seeking to combat counterfeiting and create digital product experiences.
Deep TechEnterprise SoftwareNew Materials
Frequently asked questions
- What stage does LifeSci Venture Partners invest at?
- LifeSci Venture Partners invests at the Series A, Series B, Series C stages.
- What sectors does LifeSci Venture Partners focus on?
- LifeSci Venture Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is LifeSci Venture Partners located?
- LifeSci Venture Partners is headquartered in New York, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.